What’s in an Egg: The Age-Old Vaccine Production Method Lives On | Infection Control Today
For more than 80 years, the humble chicken egg has quietly powered one of modern medicine’s most vital defenses: vaccines. Even in an age of recombinant DNA, mRNA platforms, and cell-based innovations, more than 80% of the world’s influenza vaccines still begin in an egg. The process is time-tested, affordable, and reliable—but also imperfect. read this to learn more.
For more than 80 years, the humble chicken egg has quietly powered one of modern medicine’s most vital defenses: vaccines. Even in an age of recombinant DNA, mRNA platforms, and cell-based innovations, more than 80% of the world’s influenza vaccines still begin in an egg. The process is time-tested, affordable, and reliable—but also imperfect. read this to learn more. For over 8 decades, chicken eggs have been at the heart of vaccine production. While newer technologies for vaccine development exist, egg-based vaccines still account for over 80% of influenza (flu) vaccines produced…
saved by
related reading
- The golden age of vaccine development - Works in Progress Magazineworksinprogress.co
- Making Vaccine — LessWronglesswrong.com
- Why we didn't get a malaria vaccine sooner - Works in Progress Magazineworksinprogress.co
- H5N1: Much More Than You Wanted To Knowsubstack.com
- The story of VaccinateCA - Works in Progress Magazineworksinprogress.co
- Progress Deferred: mRNA Vaccine Development Lessons | IFPifp.org
- Quebec will not administer free flu shots this falltheglobeandmail.com
- radvacradvac.org
- Vaccines | Pfizer | Pfizerpfizer.com
- Vaccine Adjuvants: Putting Innate Immunity to Workncbi.nlm.nih.gov
- How to make an antibody - Works in Progress Magazineworksinprogress.co
- mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discoverynature.com